This study aims to evaluate the activation of the IL-6/GP130/JAK/STAT3 signaling pathway in previously collected tissue samples—including pancreatic biopsies, surgical specimens, and liver biopsies—from patients diagnosed with pancreatic adenocarcinoma. The gene discussed is IL6; the disease is pancreatic adenocarcinoma.